Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

6.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
6.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ALIGNED Network for rare cerebrovascular diseases: methodology and preliminary results.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.

Cell host & microbe·2026
Same author

Experimental Approach to Moyamoya Angiopathy: Insights into Vascular Cell Crosstalk.

Cells·2026
Same author

Sex-based differences in emergency department treatment times for acute ischaemic stroke: evidence from a large Italian cohort.

European stroke journal·2026
Same author

Amyloid PET Burden, CSF Biomarkers, and <i>APOE</i> Genotype in People With Iatrogenic and Sporadic Cerebral Amyloid Angiopathy.

Neurology·2026
Same author

Neurological management and outcome measures in Fabry disease: consensus statements from the Italian Fabry disease neurological working group.

Orphanet journal of rare diseases·2026

Related Experiment Video

Updated: Mar 25, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K

Mesenchymal Stem Cells for Ischemic Stroke: Progress and Possibilities.

Anna Lucia Maria Ferri1, Anna Bersano, Daniela Lisini

  • 1Cell Therapy Production Unit, Cerebrovascular Diseases, IRCCS Foundation Neurological Institute "C. Besta", Milan, Italy. anna.ferri@istituto-besta.it.

Current Medicinal Chemistry
|February 23, 2016
PubMed
Summary
This summary is machine-generated.

Mesenchymal stromal cells (MSCs) show promise for stroke recovery by reducing inflammation and promoting new cell growth. Further research is needed to optimize MSC therapy for clinical use.

More Related Videos

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.4K
Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
10:03

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

8.3K

Related Experiment Videos

Last Updated: Mar 25, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

5.0K
A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
06:54

A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice

Published on: June 22, 2022

3.4K
Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
10:03

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

8.3K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Stroke is a leading cause of death and disability globally, with limited treatment options for many patients.
  • Current acute therapies like rt-PA and endovascular treatment benefit only a subset of ischemic stroke patients.
  • Replacing lost brain cells and restoring neural function after stroke remains a significant challenge.

Purpose of the Study:

  • To review the application of mesenchymal stromal cells (MSCs) in treating ischemic stroke.
  • To explore MSC sources, delivery methods, and measured outcomes in preclinical and clinical studies.
  • To summarize the potential benefits and challenges of MSC-based stroke therapy.

Main Methods:

  • Review of experimental data from animal stroke models.
  • Analysis of early-phase clinical trial results.
  • Examination of MSC properties, including multipotency and self-renewal.

Main Results:

  • Animal studies indicate improved functional recovery after MSC transplantation in stroke models.
  • MSCs modulate the inflammatory environment, stimulate neurogenesis and angiogenesis, and reduce glial scarring.
  • Early clinical trials suggest potential but highlight the need for optimization.

Conclusions:

  • MSCs offer a promising therapeutic avenue for ischemic stroke, influencing multiple repair mechanisms.
  • Further optimization of cell selection and administration routes is crucial for successful clinical translation.
  • Understanding the precise mechanisms of MSC action is essential for advancing stroke treatment.